Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB. 1.16

M Zappa, P Verdecchia, F Angeli - European Journal of Internal …, 2023 - ejinme.com
The World Health Organisation (WHO) estimated 780 million severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections and approximately 6.9 million deaths …

Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies

N Faraji, T Zeinali, F Joukar, MS Aleali, N Eslami… - Heliyon, 2024 - cell.com
The rapid emergence of multiple strains of Severe Acute Respiratory Syndrome Coronavirus-
2 (SARS-CoV-2) has sparked profound concerns regarding the ongoing evolution of the …

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity

E Chang-Rabley, MC van Zelm, EE Ricotta… - Vaccines, 2024 - mdpi.com
The SARS-CoV-2 pandemic has heightened concerns about immunological protection,
especially for individuals with inborn errors of immunity (IEI). While COVID-19 vaccines elicit …

Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

A Aleman, M Van Kesteren, AK Zajdman… - …, 2023 - thelancet.com
Background The real-world impact of bivalent vaccines for wild type (WA. 1) and Omicron
variant (BA. 5) is largely unknown in immunocompromised patients with Multiple Myeloma …

Bayesian phylogenetics on globally emerging SARS-CoV-2 variant BA. 2.86 suggest global distribution and rapid evolution

AP Rothstein, X Qiu, K Robison, S Collins, G Muir, B Lu… - bioRxiv, 2023 - biorxiv.org
Using bioinformatic pipelines and Bayseian phylogenetic analyses, we characterized a
SARS-CoV-2 variant designated by the World Health Organization as a variant under …

[HTML][HTML] Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection

F Angeli, M Zappa, P Verdecchia - European journal of internal medicine, 2024 - Elsevier
Several reports documented a specific effect of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on blood pressure (BP), during and after the acute phase of …

The old and the new: The EG. 5 ('Eris') sub-variant of Coronavirus

M Zappa, P Verdecchia, A Andolina… - European Journal of …, 2023 - ejinme.com
In the last year of pandemic, several variants of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) have been identified and monitored. Indeed, the persisting …

Genomic surveillance of SARS-CoV-2 in Malaysia during the era of endemic COVID-19

TY Lee, WF Lim, GY Ang, CY Yu - Life, 2023 - mdpi.com
On 5 May 2023, WHO declared the end of coronavirus disease 2019 (COVID-19) as a public
health emergency of international concern. However, the risk of new severe acute …

[PDF][PDF] A molecular docking study: benzoxazolone derivatives against SARS-CoV-2 omicron subvariant EG. 5.1

E Erdag - Chem Methodol, 2023 - sid.ir
SARS-CoV-2, the virus responsible for COVID-19, is constantly evolving, leading to the
emergence of new variants such as Omicron, which is currently dominant worldwide [1] …

[HTML][HTML] Newer COVID-19 vaccines: Still lights and shadows?

F Angeli, M Zappa, P Verdecchia - European Journal of Internal Medicine, 2023 - Elsevier
Coronavirus Disease 2019 (COVID-19) vaccines are continuing to protect people from
death, hospitalization, and severe clinical manifestations caused by severe acute respiratory …